Industry Trend

Site Sections


Menu













© 2023. All Rights reserved.

Overview for PFIZER

All Data per March 3, 2023

Industry:

Drug Manufacturers—General

Last Close:

41.15 USD

Expected Dividend:

3.96 %

Payoffs per Year:

4.0
Business Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.


Competitors View

Ordering

ABBVIE

USA
1.03 4.28%
3.61%
7.39% 5.46% 1.0 4.36
-9.47%
43.02 13.08% 10.52 1.0

CHUGAI PHARMACEUTICAL

JPN
0.96 2.56%
0.0%
22.5% 6.68% 1.0 4.24
-32.13%
32.9 15.38% 77.21 2.0

PFIZER

USA
0.95 3.64%
3.96%
2.76% 3.76% 1.0 3.02
-11.11%
49.05 9.25% 42.54 3.0

ASTRAZENECA

GBR
1.04 4.07%
2.74%
1.15% 3.92% 1.0 11.56
-3.86%
98.3 11.66% 37.27 4.0

DAIICHI SANKYO

JPN
1.05 4.24%
0.0%
0.0% 3.88% 1.0 8.15
-17.26%
35.15 18.52% 61.0 5.0

SANOFI

FRA
1.01 3.78%
4.03%
0.74% 3.58% 1.0 0.57
-12.18%
51.83 7.75% 57.12 6.0

BRISTOL-MYERS SQUIBB

USA
0.98 2.8%
3.1%
1.83% 2.78% 1.0 0.5
-24.44%
34.92 17.8% 32.88 7.0

MERCK & CO.

USA
1.12 3.12%
2.64%
2.24% 3.15% 1.0 2.31
-11.68%
55.47 10.37% 36.13 8.0

KYOWA HAKKO KOGYO

JPN
0.96 1.88%
1.67%
7.74% 2.44% 1.0 3.6
-15.61%
35.6 3.07% 79.96 9.0

GILEAD SCIENCES

USA
1.16 2.74%
3.6%
5.91% 3.26% 1.0 0.15
-42.43%
33.49 -1.11% 31.01 10.0

ELI LILLY AND COMPANY

USA
1.04 2.43%
1.22%
2.86% 2.52% 1.0 7.52
-12.71%
42.91 5.87% 18.4 11.0

ROCHE

CHE
0.92 3.28%
3.51%
0.79% 3.11% 1.0 1.4
-15.85%
37.23 2.14% 26.53 12.0

AMGEN

USA
1.0 2.42%
3.28%
8.46% 3.24% 1.0 3.5
-9.93%
35.72 -5.0% 10.95 13.0

GLAXOSMITHKLINE

GBR
0.96 5.37%
5.27%
0.35% 5.0% -0.5 0.21
-24.56%
49.96 2.63% 19.03 14.0

ASTELLAS PHARMA

JPN
0.96 2.43%
0.0%
1.74% 2.4% 1.0 1.09
-19.06%
27.18 -1.76% 60.96 15.0

OTSUKA HOLDINGS CO., LTD.

JPN
0.93 2.21%
2.54%
0.0% 2.02% 1.0 -0.41
-14.62%
28.52 12.2% 71.29 16.0

BAYER

GER
1.02 2.51%
3.99%
4.7% 2.83% 0.5 -0.36
-58.76%
36.97 -17.89% 27.46 17.0

JOHNSON & JOHNSON

USA
0.98 2.68%
0.0%
0.0% 2.46% 1.0 -1.0
13.03%
44.08 2.58% 40.67 18.0

GRIFOLS SA

ESP
0.98 1.5%
nan%
4.84% 1.7% -0.5 0.24
-46.29%
31.86 -1.95% 31.7 nan


Information for PFIZER

Yield Triangle

Dividend & Close

Close Dividend Return (%)
Year
2012 23.80 0.83 3.49
2013 29.06 0.91 3.13
2014 29.55 0.99 3.35
2015 30.63 1.06 3.46
2016 30.82 1.14 3.70
2017 34.36 1.21 3.52
2018 41.41 1.29 3.12
2019 37.17 1.37 3.69
2020 36.81 1.48 4.02
2021 59.05 1.56 2.64
2023 41.15 1.63 3.96

Fundamentals

Chart